Physician profile
Christina H Naugle
NPI 1609029305
$96,388.18
in general payments reported to CMS, 2019-2025
10 companies · $35K in 2025
The $35K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,841 · 2022: $22K · 2023: $14K · 2024: $18K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $6,664 · Food and Beverage: $3,637 · Consulting Fee: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,755.00 |
| Travel and Lodging | $6,664.48 |
| Food and Beverage | $3,637.42 |
| Consulting Fee | $725.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $65,242.76 | 2023-2025 | |
| Allergan, INC. | $30,124.72 | 2021-2022 | |
| Galderma Laboratories, L.P. | $370.58 | 2021-2025 | Dysport |
| Sientra, INC. | $303.57 | 2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $84.91 | 2022-2025 | Clear+Brilliant |
| Dilon Technologies, INC. | $81.15 | 2023 | Hemoblast Bellows |
| Revance Therapeutics, INC. | $79.46 | 2024 | Daxxify |
| Merz North America, INC. | $55.48 | 2022 | |
| Tela Bio, INC. | $25.33 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $20.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Naugle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.